Trimethoprim‐Sulfamethoxazole Activity and Pharmacodynamics against Glycopeptide‐Intermediate <i>Staphylococcus aureus</i>
Trimethoprim‐Sulfamethoxazole Activity and Pharmacodynamics against Glycopeptide‐Intermediate <i>Staphylococcus aureus</i> is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Trimethoprim‐Sulfamethoxazole Activity and Pharmacodynamics against Glycopeptide‐Intermediate <i>Staphylococcus aureus</i> have?
Trimethoprim‐Sulfamethoxazole Activity and Pharmacodynamics against Glycopeptide‐Intermediate <i>Staphylococcus aureus</i> has 23 citations in the OpenAlex counts ScholarIQ stores.
When was Trimethoprim‐Sulfamethoxazole Activity and Pharmacodynamics against Glycopeptide‐Intermediate <i>Staphylococcus aureus</i> published?
Trimethoprim‐Sulfamethoxazole Activity and Pharmacodynamics against Glycopeptide‐Intermediate <i>Staphylococcus aureus</i> has 2002 year in the ScholarIQ index.
What is the open-access status of Trimethoprim‐Sulfamethoxazole Activity and Pharmacodynamics against Glycopeptide‐Intermediate <i>Staphylococcus aureus</i>?
Trimethoprim‐Sulfamethoxazole Activity and Pharmacodynamics against Glycopeptide‐Intermediate <i>Staphylococcus aureus</i> has green oa status in the ScholarIQ index.
What is the DOI of Trimethoprim‐Sulfamethoxazole Activity and Pharmacodynamics against Glycopeptide‐Intermediate <i>Staphylococcus aureus</i>?
The DOI for Trimethoprim‐Sulfamethoxazole Activity and Pharmacodynamics against Glycopeptide‐Intermediate <i>Staphylococcus aureus</i> is on the source record.
What is the PMID of Trimethoprim‐Sulfamethoxazole Activity and Pharmacodynamics against Glycopeptide‐Intermediate <i>Staphylococcus aureus</i>?
The PMID for Trimethoprim‐Sulfamethoxazole Activity and Pharmacodynamics against Glycopeptide‐Intermediate <i>Staphylococcus aureus</i> is on the source record.
What is the OpenAlex record for Trimethoprim‐Sulfamethoxazole Activity and Pharmacodynamics against Glycopeptide‐Intermediate <i>Staphylococcus aureus</i>?
The OpenAlex for Trimethoprim‐Sulfamethoxazole Activity and Pharmacodynamics against Glycopeptide‐Intermediate <i>Staphylococcus aureus</i> is on the source record.